MedPath

Examination for the effect of combination therapy with raloxifene and eldecalcitol in postmenopausal osteoporotic patients

Not Applicable
Conditions
Osteoporosis
Registration Number
JPRN-UMIN000008440
Lead Sponsor
Kurume University, Medical Department
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are diagnosed as contraindication of raloxifene treatments. Patients who are diagnosed as contraindication of eldecalcitol treatments. Patients who are inappropriate for this study by physician.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of lumbar spine bone mineral density
Secondary Outcome Measures
NameTimeMethod
Change of total hip bone mineral density Number of fracture occurred Change of bone metabolic markers Effect of improve exercise function Safety
© Copyright 2025. All Rights Reserved by MedPath